Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Merola

Showing results (211-220 of 394) with videos related to

Pageof 40
Sort By:
The Journal of Dermatological Treatment|April 18, 2024
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trialsJoseph F Merola, April Armstrong, Saakshi Khattri, et al.
Journal of the American Academy of Dermatology|September 21, 2021
Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United StatesJoseph F Merola, Haijun Tian, Dhaval Patil, et al.
Journal of the American Academy of Dermatology|April 3, 2018
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trialKim A Papp, Joseph F Merola, Alice B Gottlieb, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2017
International Dermatology Outcome Measures (IDEOM) Group 2016 New York Meeting: Meeting Summary and Data from the Psoriasis Working GroupLourdes M Perez-Chada, Sanminder Singh, Kristina Callis-Duffin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 7, 2025
Cutaneous lupus matters: Independent and additive quality-of-life burden shown by 2022 WLFGI SurveyArianna J Zhang, Nnenna Ezeh, Beth Childs, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 31, 2022
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysisJashin J Wu, Chih-Ho Hong, Joseph F Merola, et al.
Dermatology (Basel, Switzerland)|May 22, 2019
Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM)Nicole Salame, Josefina Torres, Jeena Sandhu, et al.
Journal of the American Academy of Dermatology|September 24, 2018
A provider global assessment quality measure for clinical practice for inflammatory skin disordersAlice Gottlieb, Nicole Salame, April W Armstrong, et al.
JAMA Dermatology|May 26, 2021
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin DiseasesMaria C Schneeweiss, Seoyoung C Kim, Richard Wyss, et al.
Arthritis Care & Research|January 18, 2018
Polyarthralgias and Papulonodules in a 56-Year-Old WomanSean B Singer, Cristina Thomas, Cecilia Lezcano, et al.
Pageof 40

Showing results (211-220 of 394) with videos related to

Sort By:
Pageof 40
The Journal of Dermatological Treatment|April 18, 2024
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trialsJoseph F Merola, April Armstrong, Saakshi Khattri, et al.
Journal of the American Academy of Dermatology|September 21, 2021
Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United StatesJoseph F Merola, Haijun Tian, Dhaval Patil, et al.
Journal of the American Academy of Dermatology|April 3, 2018
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trialKim A Papp, Joseph F Merola, Alice B Gottlieb, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2017
International Dermatology Outcome Measures (IDEOM) Group 2016 New York Meeting: Meeting Summary and Data from the Psoriasis Working GroupLourdes M Perez-Chada, Sanminder Singh, Kristina Callis-Duffin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 7, 2025
Cutaneous lupus matters: Independent and additive quality-of-life burden shown by 2022 WLFGI SurveyArianna J Zhang, Nnenna Ezeh, Beth Childs, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 31, 2022
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysisJashin J Wu, Chih-Ho Hong, Joseph F Merola, et al.
Dermatology (Basel, Switzerland)|May 22, 2019
Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM)Nicole Salame, Josefina Torres, Jeena Sandhu, et al.
Journal of the American Academy of Dermatology|September 24, 2018
A provider global assessment quality measure for clinical practice for inflammatory skin disordersAlice Gottlieb, Nicole Salame, April W Armstrong, et al.
JAMA Dermatology|May 26, 2021
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin DiseasesMaria C Schneeweiss, Seoyoung C Kim, Richard Wyss, et al.
Arthritis Care & Research|January 18, 2018
Polyarthralgias and Papulonodules in a 56-Year-Old WomanSean B Singer, Cristina Thomas, Cecilia Lezcano, et al.
Pageof 40